Articles related to CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD)

The trial found no significant difference in hospitalization or death risk between patients using long-term oxygen therapy for 24 hours versus 15 hours per day, potentially offering more freedom for those with severe hypoxemia.

Proper documentation of COPD assessment using the GOLD “ABCD” tool is crucial for implementing guideline-based care and improving patient outcomes.

The randomized, controlled trial demonstrates that early intervention by pulmonologists for undiagnosed COPD and asthma results in lower health care utilization and improved patient outcomes, compared to usual primary care.

In a comprehensive analysis of COPD patients, the use of gabapentinoids was found to be associated with a 1.39 times higher risk of severe exacerbations requiring hospitalization. This finding underscores the need for cautious prescribing of these medications in the COPD population, considering their potential respiratory risks.

Are you current on the latest treatment modalities for managing dyspnea in severe COPD? Test your knowledge with this quiz and stay ahead in patient care.

The study reveals that generic Wixela Inhub is comparable to Advair Diskus in both effectiveness and safety for treating COPD. Consider this cost-effective alternative in your treatment plans.